Chronic progressive nephropath y (CPN) is the most frequently diagnosed lesion in the rat kidney. It has many component s including degeneration and regeneration of renal tubule (RT) epithelium, glomerular lesions and interstitial in ammation and brosis. The incidence and severity of CPN is strain, age, and sex dependen t and may be altered by a number of factors including exposure to xenobiotics. In National Toxicology Program (NTP) 2-year bioassays, xenobiotic-associate d increased severity (exacerbation) of CPN often occurs in association with a marginal increased incidence of renal tubule cell neoplasms (RTCN). The relationship between CPN and RTCN developmen t has not been de nitively determined. The present study evaluated the association between severity of CPN and the occurrence of RTCN in control male F344 rats. A slight but statistically signi cant increase in CPN severity was present in those animals with RTCN compared to aged-matche d controls without RTCN. Although these data suggest there is a positive correlation between CPN and RTCN, cause and effect were not determined. This marginal association suggests that the number of RTCNs that may develop secondary to chemically exacerbated nephropath y would be few.
INTRODUCTION
Chronic progressive nephropathy (CPN) is one of the most commonly recognized spontaneous lesions in the rat. The gross and microscopic features of CPN as well as the inuences of strain, age, sex, and diet have previously been described (1) (2) (3) (4) (5) . The incidence and severity of CPN can be affected by castration, hormonal status, or caloric intake (6, 7) . Chemical treatment may also alter CPN often enhancing its incidence, severity, and onset (8) .
The basic pathogenetic mechanism of CPN has not been de nitively determined as CPN is a complex disorder and most likely has a multifactoral etiology (3) . Glomerular basement membrane defects, protein-overload, glomerular hypertrophy or glomerular hyper ltration have all been postulated as possible mechanisms for the glomerular damage and subsequent nephron loss as well as the spectrum of renal lesions of CPN (9) (10) (11) . The impact CPN has on xenobiotic toxicokinetics and toxicodynamics is not fully understood. However, CPN does result in a reduction in the number of functioning nephrons, which may increase the amount of a nephrotoxic compound reaching the remaining nephrons at risk (8) . Con-versely, the mechanisms by which chemicals may alter CPN are likely as diverse as the disease itself.
The question of a relationship between CPN and proliferative lesions of the renal tubules including RTCN has been discussed with no de nitive answer (12) (13) (14) . The suggestion of a relationship is supported by data that have measured either the level of DNA synthesis or cell proliferation rates in animals with CPN (15, 16) or from studies where chemicals which enhance the severity of CPN result in a greater number of RTCN (14, 17, 18) . Enhanced proliferation in renal tubule epithelium from selected chemical treatment can result in an increased renal tumor response (19, 20) . These chemicals are often associated with enhancing CPN severity. Some studies suggest that increased cell proliferation within foci of CPN secondary to chemical toxicity may increase the risk for RTCN development (13, 20) . Clearly chemical toxicity and increased cell proliferation may not be the only factors that contribute to a renal tumor response (22, 23) . For example, there are chemicals that enhance CPN but do not induce RTCN (24, 25) . Furthermore, the historical rate of RTCN in rat strains with a high incidence of CPN is generally less than 1% (26) (27) (28) .
Understanding the relationship of CPN or chemically enhanced CPN and RTCN incidence will allow a more scienti cally relevant evaluation of data from safety studies and result in more accurate risk characterization. In NTP studies, this is of particular concern in male rats as the incidence and severity of CPN in the F344 rat is most severe in the males. Also in NTP studies, the spontaneous rate of RTCN is greater in males than in females and increases in RTCN 682 SEELY ET AL TOXICOLOGIC PATHOLOGY considered to be treatment-related occurred in male rats in 42 studies and in females in 13 studies (27, 29) . The present study was designed to determine whether a possible association may exist between CPN and RTCN development in control animals.
MATERIALS AND METHODS This retrospectiveevaluation was composed of 2 parts. The rst part involved a data base search of approximately 500 previous NTP chronic (generally 2-year) studies (via all routes; inhalation, dosed feed, dosed water, gavage, and dermal) to identify those in which RTCNs (adenoma/carcinoma ) were present in control, male Fischer 344 (F344) rats. For each study in which a neoplasm was identi ed, the CPN severity grades for tumor-bearing and selected non-tumorbearing animals were determined and the RTCN con rmed. All kidneys were examined by the same pathologist (JCS).
Pathology diagnoses in NTP studies are subjected to a rigorous peer review to assure the accuracy of both neoplastic and nonneoplastic diagnoses within a study (30) . Similarly, there is an effort to assure diagnostic consistency for neoplastic lesions across NTP studies. However, consistency of diagnostic schemes for grading nonneoplastic effects, including CPN, across studies is not always achieved. Therefore, for the purpose of the rst retrospective evaluation it was deemed necessary to conduct a microscopic reexamination of the kidneys to more consistently grade the CPN severity across the studies. CPN grading schemes, as for most tissues, are subjective and generally based on an estimate of the percentage of the parenchyma involved (31) . A 4-grade severity scale is somewhat standard and routinely used in NTP studies. However, the use of additional grades may be helpful when trying to sort out features within a complex lesion. Therefore for this rst part reevaluation, a 5-grade scale was used as presented in Table 1 ; both kidneys were examined and graded separately.
Because the severity of CPN progresses with time, agematched, non-tumor-bearing control animals from within each individual study were selected to compare the severity of CPN with the tumor-bearing controls. For tumor-bearing controls that lived to terminal sacri ce (TSAC), kidneys from all other TSAC controls were examined for CPN severity. For tumor-bearing controls that died or were moribund-sacri ced within 30 days of TSAC, all animals that died or were moribund sacri ced between the date of death/moribund sacri ce of the tumor-bearing animal and TSAC plus an equal number that died/moribund sacri ced before the tumor-bearing control were used for comparison. For tumor-bearing control animals that died or were moribund-sacri ced 31 days of TSAC, all control rats that died or were moribund sacri- ced within 30 days before or after the tumor-bearing animals were used for comparison. Comparisons between the TSAC controls were done separately from those of the early death/moribund sacri ce animals.
Because the number of control animals with RTCN was somewhat limited, a second retrospective analysis was done to compare CPN severity between tumor-bearing and nontumor-bearing animals. In this analysis, the severity of CPN was compared between tumor-bearing animals and nontumor-bearing animals from 2-year studies (control and treated animals) of 15 chemicals in which renal step-sections had been prepared. The kidneys from these studies had extensive peer review because of a potential tumorigenic response in the kidney, and the section procedure resulted in examination of additional sections of kidneys. Because these kidneys had been thoroughly peer reviewed and because comparisons across studies were not critical, the kidneys from these studies were not re-examined. Therefore, the standard NTP 4-grade severity was retained. In each of these studies, comparisons were made between tumor-bearing and non-tumor-bearing animals from within a dose group (control or treated). Comparisons were not made across dose groups because of the potential confounding effect of chemical administration. For each dose group, the mean survival period (days) was determined for tumor-bearing animals. For non-tumor-bearing animals, an equivalent aged-matched group of animals was selected for comparison.
In these 15 studies, step sectioning of kidneys was originally conducted to help establish a relationship, if any, between chemical administration and proliferative RT lesions of the male rat. In these studies, the remaining formalin-xed kidney halves were embedded and single sections taken every 1 mm. This produced an additional 6-8 H&E stained sections per animal with equal sampling between control and treated groups (32) . These sections were examined for proliferative lesions of the renal tubule, and the results peer reviewed.
Comparisons of nephropathy severities in tumor-bearing and tumor-free animals were made using the Wilcoxon signed rank test (33) .
RESULTS
RTCNs were identi ed in 38 male control rats that were terminally sacri ced (generally at 2 years) on study from a total of 28 studies (chemicals). The severity of CPN was compared between control animals with RTCNs and those without by a Wilcoxon signed-rank test applied to the severity differences from the 28 studies (Table 2) . Table 3 summarizes the distribution of CPN severity between male rats with and without RTCNs for terminally sacri ced animals. The 38 tumor-bearing animals had a mean CPN severity of 4.09, while 577 nontumor-bearing animals had a mean CPN severity of 3.75. The difference of 0.34 was statistically signi cant ( p < 0.05). In 18 of the 28 studies the severity of CPN was greater in the tumor-bearing controls.
RTCNs were identi ed in 34 male rats that died (natural and/or moribund sacri ce) early from a total of 27 NTP 2-year studies (chemicals). Table 4 compares the severity of CPN between control animals with RTCNs age-matched animals without a RTCN. Table 5 summarizes the distribution of CPN severity between early death male rats with and Vol. 30, No. 6, 2002 CHRONIC PROGRESSIVE NEPHROPATHY AND RENAL TUBULE CELL NEOPLASMS 683 In Table 6 the severity of CPN between tumor-bearing and non-tumor-bearing animals from 15 NTP studies in which additional sections (step sections) of the kidney had been taken is compared. Unlike the comparisons before where only control animals were evaluated, both control and treated animals were evaluated in this part of the retrospective analysis. However, to avoid the potential for a confounding effect of chemical administration, comparisons were made only within each study group (controls or individual treatment group) and not across study groups. The mean CPN severity grades for all animals with tumors were compared to the mean severity of a subgroup of age-matched, non-tumor-bearing animals from that same group. The total number of tumor-bearing and non-tumor-bearing animals are in parentheses in Table 6 . From the 15 studies, a total of 54 control and dosed groups ( Table 6 ) were analyzed. Approximately 87% of these groups had higher mean CPN severity grades in the tumor-bearing animals than in a corresponding group of aged-matched animals. The mean difference of 0.35 was statistically signi cant ( p < 0.05).
DISCUSSION
Within the NTP 2-year carcinogenicity studies, the kidney is the second most commonly affected site for chemically associated site-speci c neoplasms (29) . In the majority of the studies, the response is speci c to the male F344 rat and the observed increased incidences of renal neoplasms are relatively low. The increases are primarily of adenomas, and in many instances there is a concurrent dose-related increase in the severity of CPN. Nearly 100% of male rats that live for 2 years have some degree of CPN, therefore chemically exacerbated CPN is generally detected by an increase in severity rather than increases in incidence.
Generally, in NTP studies with chemical-related increased incidences of RTCNs, there is no readily apparent mechanism by which the renal proliferative lesions developed. The possible modes of chemically induced neoplasia in the kidney are likely as varied as in any organ with genotoxic and nongenotoxic (epigenetic) modes applicable (12, 13, (20) (21) (22) 34) . With many of the epigenetic mechanisms, the magnitude of chemically induced neoplasms is likely to be less than those associated with genetic alterations. Under the "epigenetic" umbrella, it is theorized that chemicals may TOXICOLOGIC PATHOLOGY induce a slight increase in RTCNs indirectly via exacerbation of spontaneous CPN. It stands to reason and has been shown that there is increased cell proliferation in kidneys with more severe CPN (3, 15) . Also, in a recent study, indices associated with increased cell proliferation were noted in the kidney of a male F344 rat bearing a unilateral renal tubule neoplasm as compared to the contralateral kidney (35) . If there were a known causal relationship between exacerbation of CPN and occurrence of RTCNs, some of the increases observed in NTP studies might be considered secondary to the exacerbated CPN rather than a potential direct effect of the chemical. Therefore, understanding the relationship between CPN and RTCNs is important for evaluation of the responses in these studies. However, attempting to tease out any causal association between CPN and RT proliferative lesions, particularly tumors, is frought with problems. For instance, analyses of data from studies with treatmentrelated increased incidences of RTCNs and exacerbated CPN are potentially confounded because the exacerbated CPN and RTCNs may be independent effects or affected by other Table 4 .
factors (eg, mitogenesis, oxidative stress). As mentioned previously, there are chemicals that enhance CPN but do not induce RTCN and the historical control rate of RTCN in rat strains with a high incidence of CPN is generally less than 1%. The current retrospective analyses represent an initial step in an ongoing project to further de ne this somewhat contradictory relationship and to try to answer the more important question of the role of CPN in the interpretation of marginal elevations of RTCNs in chemical treatment groups. It should be acknowledged that a more direct approach in assessing the impact of CPN on RTCN would have been to take a large group of equivalently aged animals with varying CPN severities and compare the observed rates of RTCN. However, this approach was infeasible, because the rarity of RTCN would have required an inordinately large sample size to evaluate this association. Our approach, which focused on RTCN initially rather than CPN, demonstrated that an association exists between CPN severity and RTCN, but it is not possible from the data we have generated to determine the exact magnitude of the change in RTCN rate due to severe CPN.
RTCNs were identi ed in 72 control male F344 rats in over 50 of the 2-year carcinogenicity studies conducted by the NTP. Compared to age-matched controls within the individual studies, the mean CPN severity grade of tumor-bearing controls was statistically signi cantly increased slightly. The mean CPN severity grade difference for terminally sacri ced animals and early-death animals was similar (0.34 vs 0.40) when using a 5-grade CPN severity scale. A review of data of both control and treated male rats from 15 NTP studies in which expanded evaluations of the kidney were completed showed a strikingly similar differential (0.35) even though the original NTP 4-grade CPN severity grading scale was used.
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While the pathogenesis of chemically induced RTCN is dif cult to determine, and will need to be sorted out on a caseby-case basis, the data from these retrospective reviews suggest that an increased severity of CPN may contribute to the overall tumor response. However, any contribution appears to be marginal, and additional factors are likely involved. More studies investigating CPN, spontaneous or chemically exacerbated, are necessary to fully understand the complex nature of the relationship.
Several reports have also suggested that there may be a genetic component in the development of some renal tubule neoplasms in F344 rats (36, 37) . In one report, neoplasms with similar histologic features were observed in animals from 90-day toxicity studies (37) . These genetically susceptible animals may be more likely to develop neoplasms as they age and have increased CPN.
Recently, the NTP began to use a new diet in their chronic studies (38) . This new diet (NTP-2000) contains less protein and more ber and fat than the previously used NIH-07 diet, and was designed to increase longevity and to decrease some spontaneous age-related lesions including CPN. Thus far there are 906 control male rats in the database via all routes, and the incidence of renal tubule adenoma and carcinoma is 3/906 (0.33%). This compares to 14/1,052 (1.3%) in inhalation and 8/1,002 (0.8%) in feed studies in which the NIH-07 diet was used. NTP-2000 has also been shown to reduce the severity of CPN. In a study comparing CPN in the NTP-2000 diet vs the NIH-07 diet, the mean severity of CPN was 1.86 for the NTP-2000 diet compared to the NIH-07 diet of 2.62 based on a NTP 4-grade severity scale (39) . It will be interesting to see if this trend of fewer spontaneous RTCNs in association with less severe CPN continues as more studies are performed using the NIH-2000 diet.
In summary, the present study suggests that there is an association between an increased severity of CPN and RTCNs. The difference in CPN severity between the tumor-bearing and non-tumor-bearing animals was consistent across the 3 study subsets. Marginal increases in RTCNs may be partially explained by exacerbated CPN in NTP studies. Additional work is necessary to de nitively answer this question.
